| 标题 |
MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of oncology : official journal of the European Society for Medical Oncology 作者:Aldea M; Lenahan SM; Locquet MA; Liao L; Gasparro M; et al 出版日期:2026/07/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)